"Dopamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.
| Descriptor ID |
D004298
|
| MeSH Number(s) |
D02.092.211.215.311.342 D02.092.311.342
|
| Concept/Terms |
Dopamine- Dopamine
- 4-(2-Aminoethyl)-1,2-benzenediol
- Hydroxytyramine
- 3,4-Dihydroxyphenethylamine
- 3,4 Dihydroxyphenethylamine
|
Below are MeSH descriptors whose meaning is more general than "Dopamine".
Below are MeSH descriptors whose meaning is more specific than "Dopamine".
This graph shows the total number of publications written about "Dopamine" by people in this website by year, and whether "Dopamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 1 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 3 | 3 | 6 |
| 2002 | 3 | 2 | 5 |
| 2003 | 4 | 1 | 5 |
| 2004 | 3 | 2 | 5 |
| 2005 | 2 | 5 | 7 |
| 2006 | 3 | 5 | 8 |
| 2007 | 3 | 2 | 5 |
| 2008 | 4 | 2 | 6 |
| 2009 | 8 | 7 | 15 |
| 2010 | 3 | 2 | 5 |
| 2011 | 8 | 3 | 11 |
| 2012 | 2 | 4 | 6 |
| 2013 | 3 | 0 | 3 |
| 2014 | 3 | 2 | 5 |
| 2015 | 2 | 2 | 4 |
| 2016 | 0 | 1 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 2 | 3 |
| 2020 | 1 | 0 | 1 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dopamine" by people in Profiles.
-
Douaki A, Stuber A, Hengsteler J, Momotenko D, Rogers DM, Rocchia W, Hirst JD, Nakatsuka N, Garoli D. Theoretical analysis of divalent cation effects on aptamer recognition of neurotransmitter targets. Chem Commun (Camb). 2023 Dec 12; 59(99):14713-14716.
-
Amin M, Horst N, Gragnoli C. Linkage and association of variants in the dopamine receptor 2 gene (DRD2) with polycystic ovary syndrome. J Ovarian Res. 2023 Aug 10; 16(1):158.
-
Kopruszinski CM, Vizin R, Watanabe M, Martinez AL, de Souza LHM, Dodick DW, Porreca F, Navratilova E. Exploring the neurobiology of the premonitory phase of migraine preclinically - a role for hypothalamic kappa opioid receptors? J Headache Pain. 2022 Sep 30; 23(1):126.
-
Froehlich M, Koizumi N, James RM, Christian AGW, Choubey A, Patel S, Ortiz J, Siskind EJ. The Use of Vasopressors During Deceased Donor Pancreas Procurement Decreases the Risk of Pancreas Transplant Graft Failure. Pancreas. 2022 08 01; 51(7):747-751.
-
Smeyne RJ, Eells JB, Chatterjee D, Byrne M, Akula SM, Sriramula S, O'Rourke DP, Schmidt P. COVID-19 Infection Enhances Susceptibility to Oxidative Stress-Induced Parkinsonism. Mov Disord. 2022 07; 37(7):1394-1404.
-
Peng K, McIlroy DR, Bollen BA, Billings FT, Zarbock A, Popescu WM, Fox AA, Shore-Lesserson L, Zhou S, Geube MA, Ji F, Bhatia M, Schwann NM, Shaw AD, Liu H. Society of Cardiovascular Anesthesiologists Clinical Practice Update for Management of Acute Kidney Injury Associated With Cardiac Surgery. Anesth Analg. 2022 10 01; 135(4):744-756.
-
Schneider JS, Singh G, Williams CK, Singh V. GM1 ganglioside modifies microglial and neuroinflammatory responses to a-synuclein in the rat AAV-A53T a-synuclein model of Parkinson's disease. Mol Cell Neurosci. 2022 05; 120:103729.
-
Bustin A, Ramsey EZ, Hanna BD, Kaushal G. Compatibility of treprostinil sodium and dopamine hydrochloride during simulated Y-site administration. Am J Health Syst Pharm. 2020 Apr 01; 77(8):649-657.
-
Monti DA, Newberg AB. Response to "Potential Role of N-Acetyl Cysteine in the Cysteine Proteome in Parkinson's Disease?" Clin Pharmacol Ther. 2020 05; 107(5):1056.
-
Schneider JS, Aras R, Williams CK, Koprich JB, Brotchie JM, Singh V. GM1 Ganglioside Modifies a-Synuclein Toxicity and is Neuroprotective in a Rat a-Synuclein Model of Parkinson's Disease. Sci Rep. 2019 06 10; 9(1):8362.